The Trump administration hopes to curb a startling rise in improper Medicaid payments by stepping up its crackdown on ineligible program beneficiaries.

House Judiciary Cmtelawmakers offer bill that would give the Federal Trade Commission the authority to prosecute pharmaceutical manufacturers that create non-substantive changes to prescriptions.

Seven requests to take experimental drugs under right-to-try laws are before a large commercial ethics board for review, indicating more patients may be using the controversial pathway than originally thought.

Reports the Trump administration is backing off a promise to crack down on teen vaping may spur Congress to act on the issue instead.

An amendment to the Florida Constitution that requires health-care providers to give patients access to adverse medical incident reports doesn’t invalidate a state law that prohibits internal risk management program data from being admitted at trial, a Florida appeals court said.

The Health and Human Services Department correctly refused to delete a hospital’s National Practitioner Data Bank report about a doctor because he was under investigation when he resigned his medical staff privileges, a District of Columbia federal court said.